Global Rectal Mesalazine Supply, Demand and Key Producers, 2023-2029

February 2023 | 95 pages | ID: G80A6C839B5EEN
GlobalInfoResearch

Abstracts

This report studies the global Rectal Mesalazine demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Rectal Mesalazine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Rectal Mesalazine that contribute to its increasing demand across many markets.

The global Rectal Mesalazine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study

Global Rectal Mesalazine total market, 2018-2029, (USD Million)

Global Rectal Mesalazine total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Rectal Mesalazine total market, key domestic companies and share, (USD Million)

Global Rectal Mesalazine revenue by player and market share 2018-2023, (USD Million)

Global Rectal Mesalazine total market by Type, CAGR, 2018-2029, (USD Million)

Global Rectal Mesalazine total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Rectal Mesalazine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ferring Global, AbbVie, Reid-Rowell, Dr. Falk Pharma UK and Alaven Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Rectal Mesalazine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Rectal Mesalazine Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Rectal Mesalazine Market, Segmentation by Type

• Suppository
• Enema

Global Rectal Mesalazine Market, Segmentation by Application

• Ulcerative Colitis
• Crohn's Disease
• Inflammatory Bowel Disease

Companies Profiled:

• Ferring Global
• AbbVie
• Reid-Rowell
• Dr. Falk Pharma UK
• Alaven Pharmaceutical

Key Questions Answered

1. How big is the global Rectal Mesalazine market?

2. What is the demand of the global Rectal Mesalazine market?

3. What is the year over year growth of the global Rectal Mesalazine market?

4. What is the total value of the global Rectal Mesalazine market?

5. Who are the major players in the global Rectal Mesalazine market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Rectal Mesalazine Introduction
1.2 World Rectal Mesalazine Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Rectal Mesalazine Total Market by Region (by Headquarter Location)
  1.3.1 World Rectal Mesalazine Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Rectal Mesalazine Market Size (2018-2029)
  1.3.3 China Rectal Mesalazine Market Size (2018-2029)
  1.3.4 Europe Rectal Mesalazine Market Size (2018-2029)
  1.3.5 Japan Rectal Mesalazine Market Size (2018-2029)
  1.3.6 South Korea Rectal Mesalazine Market Size (2018-2029)
  1.3.7 ASEAN Rectal Mesalazine Market Size (2018-2029)
  1.3.8 India Rectal Mesalazine Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Rectal Mesalazine Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Rectal Mesalazine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Rectal Mesalazine Consumption Value (2018-2029)
2.2 World Rectal Mesalazine Consumption Value by Region
  2.2.1 World Rectal Mesalazine Consumption Value by Region (2018-2023)
  2.2.2 World Rectal Mesalazine Consumption Value Forecast by Region (2024-2029)
2.3 United States Rectal Mesalazine Consumption Value (2018-2029)
2.4 China Rectal Mesalazine Consumption Value (2018-2029)
2.5 Europe Rectal Mesalazine Consumption Value (2018-2029)
2.6 Japan Rectal Mesalazine Consumption Value (2018-2029)
2.7 South Korea Rectal Mesalazine Consumption Value (2018-2029)
2.8 ASEAN Rectal Mesalazine Consumption Value (2018-2029)
2.9 India Rectal Mesalazine Consumption Value (2018-2029)

3 WORLD RECTAL MESALAZINE COMPANIES COMPETITIVE ANALYSIS

3.1 World Rectal Mesalazine Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Rectal Mesalazine Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Rectal Mesalazine in 2022
  3.2.3 Global Concentration Ratios (CR8) for Rectal Mesalazine in 2022
3.3 Rectal Mesalazine Company Evaluation Quadrant
3.4 Rectal Mesalazine Market: Overall Company Footprint Analysis
  3.4.1 Rectal Mesalazine Market: Region Footprint
  3.4.2 Rectal Mesalazine Market: Company Product Type Footprint
  3.4.3 Rectal Mesalazine Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Rectal Mesalazine Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Rectal Mesalazine Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Rectal Mesalazine Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Rectal Mesalazine Consumption Value Comparison
  4.2.1 United States VS China: Rectal Mesalazine Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Rectal Mesalazine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Rectal Mesalazine Companies and Market Share, 2018-2023
  4.3.1 United States Based Rectal Mesalazine Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Rectal Mesalazine Revenue, (2018-2023)
4.4 China Based Companies Rectal Mesalazine Revenue and Market Share, 2018-2023
  4.4.1 China Based Rectal Mesalazine Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Rectal Mesalazine Revenue, (2018-2023)
4.5 Rest of World Based Rectal Mesalazine Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Rectal Mesalazine Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Rectal Mesalazine Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Rectal Mesalazine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Suppository
  5.2.2 Enema
5.3 Market Segment by Type
  5.3.1 World Rectal Mesalazine Market Size by Type (2018-2023)
  5.3.2 World Rectal Mesalazine Market Size by Type (2024-2029)
  5.3.3 World Rectal Mesalazine Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Rectal Mesalazine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Ulcerative Colitis
  6.2.2 Crohn's Disease
  6.2.3 Inflammatory Bowel Disease
6.3 Market Segment by Application
  6.3.1 World Rectal Mesalazine Market Size by Application (2018-2023)
  6.3.2 World Rectal Mesalazine Market Size by Application (2024-2029)
  6.3.3 World Rectal Mesalazine Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Ferring Global
  7.1.1 Ferring Global Details
  7.1.2 Ferring Global Major Business
  7.1.3 Ferring Global Rectal Mesalazine Product and Services
  7.1.4 Ferring Global Rectal Mesalazine Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Ferring Global Recent Developments/Updates
  7.1.6 Ferring Global Competitive Strengths & Weaknesses
7.2 AbbVie
  7.2.1 AbbVie Details
  7.2.2 AbbVie Major Business
  7.2.3 AbbVie Rectal Mesalazine Product and Services
  7.2.4 AbbVie Rectal Mesalazine Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 AbbVie Recent Developments/Updates
  7.2.6 AbbVie Competitive Strengths & Weaknesses
7.3 Reid-Rowell
  7.3.1 Reid-Rowell Details
  7.3.2 Reid-Rowell Major Business
  7.3.3 Reid-Rowell Rectal Mesalazine Product and Services
  7.3.4 Reid-Rowell Rectal Mesalazine Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Reid-Rowell Recent Developments/Updates
  7.3.6 Reid-Rowell Competitive Strengths & Weaknesses
7.4 Dr. Falk Pharma UK
  7.4.1 Dr. Falk Pharma UK Details
  7.4.2 Dr. Falk Pharma UK Major Business
  7.4.3 Dr. Falk Pharma UK Rectal Mesalazine Product and Services
  7.4.4 Dr. Falk Pharma UK Rectal Mesalazine Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Dr. Falk Pharma UK Recent Developments/Updates
  7.4.6 Dr. Falk Pharma UK Competitive Strengths & Weaknesses
7.5 Alaven Pharmaceutical
  7.5.1 Alaven Pharmaceutical Details
  7.5.2 Alaven Pharmaceutical Major Business
  7.5.3 Alaven Pharmaceutical Rectal Mesalazine Product and Services
  7.5.4 Alaven Pharmaceutical Rectal Mesalazine Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Alaven Pharmaceutical Recent Developments/Updates
  7.5.6 Alaven Pharmaceutical Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Rectal Mesalazine Industry Chain
8.2 Rectal Mesalazine Upstream Analysis
8.3 Rectal Mesalazine Midstream Analysis
8.4 Rectal Mesalazine Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Rectal Mesalazine Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Rectal Mesalazine Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Rectal Mesalazine Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Rectal Mesalazine Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Rectal Mesalazine Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Rectal Mesalazine Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Rectal Mesalazine Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Rectal Mesalazine Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Rectal Mesalazine Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Rectal Mesalazine Players in 2022
Table 12. World Rectal Mesalazine Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Rectal Mesalazine Company Evaluation Quadrant
Table 14. Head Office of Key Rectal Mesalazine Player
Table 15. Rectal Mesalazine Market: Company Product Type Footprint
Table 16. Rectal Mesalazine Market: Company Product Application Footprint
Table 17. Rectal Mesalazine Mergers & Acquisitions Activity
Table 18. United States VS China Rectal Mesalazine Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Rectal Mesalazine Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Rectal Mesalazine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Rectal Mesalazine Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Rectal Mesalazine Revenue Market Share (2018-2023)
Table 23. China Based Rectal Mesalazine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Rectal Mesalazine Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Rectal Mesalazine Revenue Market Share (2018-2023)
Table 26. Rest of World Based Rectal Mesalazine Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Rectal Mesalazine Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Rectal Mesalazine Revenue Market Share (2018-2023)
Table 29. World Rectal Mesalazine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Rectal Mesalazine Market Size by Type (2018-2023) & (USD Million)
Table 31. World Rectal Mesalazine Market Size by Type (2024-2029) & (USD Million)
Table 32. World Rectal Mesalazine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Rectal Mesalazine Market Size by Application (2018-2023) & (USD Million)
Table 34. World Rectal Mesalazine Market Size by Application (2024-2029) & (USD Million)
Table 35. Ferring Global Basic Information, Area Served and Competitors
Table 36. Ferring Global Major Business
Table 37. Ferring Global Rectal Mesalazine Product and Services
Table 38. Ferring Global Rectal Mesalazine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Ferring Global Recent Developments/Updates
Table 40. Ferring Global Competitive Strengths & Weaknesses
Table 41. AbbVie Basic Information, Area Served and Competitors
Table 42. AbbVie Major Business
Table 43. AbbVie Rectal Mesalazine Product and Services
Table 44. AbbVie Rectal Mesalazine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. AbbVie Recent Developments/Updates
Table 46. AbbVie Competitive Strengths & Weaknesses
Table 47. Reid-Rowell Basic Information, Area Served and Competitors
Table 48. Reid-Rowell Major Business
Table 49. Reid-Rowell Rectal Mesalazine Product and Services
Table 50. Reid-Rowell Rectal Mesalazine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Reid-Rowell Recent Developments/Updates
Table 52. Reid-Rowell Competitive Strengths & Weaknesses
Table 53. Dr. Falk Pharma UK Basic Information, Area Served and Competitors
Table 54. Dr. Falk Pharma UK Major Business
Table 55. Dr. Falk Pharma UK Rectal Mesalazine Product and Services
Table 56. Dr. Falk Pharma UK Rectal Mesalazine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Dr. Falk Pharma UK Recent Developments/Updates
Table 58. Alaven Pharmaceutical Basic Information, Area Served and Competitors
Table 59. Alaven Pharmaceutical Major Business
Table 60. Alaven Pharmaceutical Rectal Mesalazine Product and Services
Table 61. Alaven Pharmaceutical Rectal Mesalazine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Rectal Mesalazine Upstream (Raw Materials)
Table 63. Rectal Mesalazine Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Rectal Mesalazine Picture
Figure 2. World Rectal Mesalazine Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Rectal Mesalazine Total Market Size (2018-2029) & (USD Million)
Figure 4. World Rectal Mesalazine Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Rectal Mesalazine Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Rectal Mesalazine Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Rectal Mesalazine Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Rectal Mesalazine Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Rectal Mesalazine Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Rectal Mesalazine Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Rectal Mesalazine Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Rectal Mesalazine Revenue (2018-2029) & (USD Million)
Figure 13. Rectal Mesalazine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Rectal Mesalazine Consumption Value (2018-2029) & (USD Million)
Figure 16. World Rectal Mesalazine Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Rectal Mesalazine Consumption Value (2018-2029) & (USD Million)
Figure 18. China Rectal Mesalazine Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Rectal Mesalazine Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Rectal Mesalazine Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Rectal Mesalazine Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Rectal Mesalazine Consumption Value (2018-2029) & (USD Million)
Figure 23. India Rectal Mesalazine Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Rectal Mesalazine by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Rectal Mesalazine Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Rectal Mesalazine Markets in 2022
Figure 27. United States VS China: Rectal Mesalazine Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Rectal Mesalazine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Rectal Mesalazine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Rectal Mesalazine Market Size Market Share by Type in 2022
Figure 31. Suppository
Figure 32. Enema
Figure 33. World Rectal Mesalazine Market Size Market Share by Type (2018-2029)
Figure 34. World Rectal Mesalazine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Rectal Mesalazine Market Size Market Share by Application in 2022
Figure 36. Ulcerative Colitis
Figure 37. Crohn's Disease
Figure 38. Inflammatory Bowel Disease
Figure 39. Rectal Mesalazine Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source